Drug profile · INN
acalabrutinib
CALQUENCE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
acalabrutinib (CALQUENCE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN acalabrutinib
Brand CALQUENCE
Route ORAL
Formulation CAPSULE
ATC code L01EL02
Frequently asked questions
What is acalabrutinib?
acalabrutinib (CALQUENCE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for acalabrutinib?
CALQUENCE is a marketed brand name for acalabrutinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of acalabrutinib?
acalabrutinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.